Skip to content

新闻稿

Illumina与NRGene合作,为支持全球食物生产加速推进牛群分子育种工具的开发

双方共同与圣保罗州立大学完成了Nellore牛基因组的高质量组装

圣地亚哥 & 与以色列耐斯茨奥纳 -- 2017年1月12日-- 新一代测序技术的全球领先公司Illumina(纳斯达克股票代码:ILMN)与基因组装和分析的全球领先企业NRGene,今日宣布合作开发牛群分子育种工具。作为合作计划的第一步,双方同时也宣布已经与巴西圣保罗州立大学的研究人员共同完成了Nellore牛基因组的高质量组装。

本新闻稿包含多媒体内容。请点击以下链接查看全部内容:http://www.businesswire.com/news/home/20170112005228/en/

双方将会共同对更多不同品种的牛只进行测序和组装,以更快了解各个牛种群的遗传变异。此次合作将有助于开发用于牛基因组选择和其他基因组技术的商业工具,从而加快开展育种项目,增进全球食物(肉类和乳制品)产量。

“我们期待与NRGene进行下一阶段的战略合作,通过更多的测序研究加速推进全球的牛群育种,最终将改良的基因组选择工具商业化,”Illumina应用基因组学副总裁兼总经理Rob Brainin说。“我们对牛基因组的认识正在不断增加,将会在全球持续支持大量的育种项目,在帮助提高产量、改善消费者行为的同时,满足全球对安全、营养、健康的蛋白质产品的需求。”

Nellore (bos indicus)是热带地区作为食物生产的主要瘤牛品种。此次基因组测序和组装使用了Illumina的新一代测序数据和NRGene的云端DeNovoMAGICTM 3.0组装软件组合。随着牛群基因组数据的增加,将会使用NRGene的PanMAGICTM来比较多个完整独立样本的基因组序列,从而分析这些基因组的多样性。这些信息将用于设计更高效的基因分析工具以支持牛群育种项目。

“Illumina和NRGene的技术让我们在短短两个月内就精确组装了Nellore牛的一个杂合子基因组,”圣保罗州立大学教授Jose Fernando Garcia说。“我们相信这个参考基因组会帮助巴西牛群育种人员极大提高本地牛的产量,更重要的是将会为Nellore牛的繁殖和肉质提供重要的信息,为全球的产量增值。”

NRGene和Illumina的技术组合已经在其他农业计划中得到应用,来解码某些最重要的基因组,这些基因组包括六倍体小麦、四倍体杂合子芒果、八倍体杂合子草莓,以及十几种新型玉米、黄豆、棉花和加拿大低酸油菜籽的基因组。

“通过我们不断开发的基因分型和育种工具,此类牛基因的组装进一步揭示了牛群的多样性,”NRGene CEO Gil Ronen说。“我们技术的终极价值在于将来能够分析并加速作物、牲畜和水产等各个农业品种的育种。”

关于 Illumina

Illumina公司通过解码基因组而改善人类健康。我们注重创新,这使我们成为DNA测序和芯片技术的全球领导者,并为科研、临床和应用市场的客户提供服务。我们的产品应用在生命科学、肿瘤学、生殖保健、农业及其他新兴市场上。如欲了解更多信息,请访问:www.illumina.com.cn 或关注@illumina。

关于NRGene

NRGene是一家基因组大数据公司,开发尖端的软件与算法,分析复杂与多样的作物、动物与水产,支持最高端的先进育种项目。NRGene的工具已经在世界一些领先的种子公司以及学术界最有影响力的研究团队中得到应用。www.nrgene.com

Illumina Forward-Looking Statements

This release contains forward-looking statements that involve risks and uncertainties, such as Illumina’s expectations regarding the launch of any products. Among the important factors that could cause actual results to differ materially from those in any forward-looking statements are (i) our ability to further develop and commercialize our instruments and consumables and to deploy new products, services, and applications, and expand the markets, for our technology platforms; (ii) our ability to manufacture robust instrumentation and consumables; (iii) achievement and timing of the planned deconsolidation of GRAIL, Inc.’s financial results in our financial statements; (iv) our ability to successfully identify and integrate acquired technologies, products, or businesses; (v) our expectations and beliefs regarding future conduct and growth of the business and the markets in which we operate; (vi) challenges inherent in developing, manufacturing, and launching new products and services; and (vii) the application of generally accepted accounting principles, which are highly complex and involve many subjective assumptions, estimates, and judgments, together with other factors detailed in our filings with the Securities and Exchange Commission, including our most recent filings on Forms 10-K and 10-Q, or in information disclosed in public conference calls, the date and time of which are released beforehand. We undertake no obligation, and do not intend, to update these forward-looking statements, to review or confirm analysts’ expectations, or to provide interim reports or updates on the progress of the current quarter.

 

来源:Illumina公司

Illumina公司
Investors:
Rebecca Chambers
858-255-5243
rchambers@illumina.com
or
Media:
Gwen Gordon
858-882-6822
pr@illumina.com
or
NRGene
K2 Global Communications
Amy Kenigsberg
+1-913-440-4072 (+7 ET)
+972-9-794-1681 (+2 GMT)
amy@k2-gc.com

 

Recent Articles

Veterans Find New Rewards at Illumina
Veterans Find New Rewards at Illumina
Opening Doors for Students and the Possibilities of a STEM Career
Opening Doors for Students and the Possibilities of a STEM Career
Let it Grow: A DNA Database for Plants, One Species at a Time
Let it Grow: A DNA Database for Plants, One Species at a Time